Healthcare

For an insurer, the medical loss ratio is the single most watched operating measure, because it determines how much of each premium dollar remains to cover administrative costs and profit. A drop of 4.5 percentage points in one year is a large move, and …

Medical technology companiesSupplydevices, diagnostics and infusion and specimen-collection products to hospitals, laboratories and clinics.Demandis shaped by hospital budgets, procedure volumes, reimbursement rules and regulatory approvals. Because products are sold to health systems with long purchasing cycles, growth tends to be continuing rather than abrupt.

The quarter's revenue increase of about $3.5 billion, from $64.0 billion to $67.5 billion, is larger in dollar terms than the entire operating earnings figure, which illustrates how thin theMarginon distributed products is relative to sales. For that reason, the company's earnings trends depend …

Total revenues for the quarter were $73.7 billion, compared with $69.7 billion in the third quarter of 2025, and the company reported that revenues grew about 6% on that basis. Adjusted revenues exclude special items and include the company's share of certain joint ventureInvestmentresults, …

Third-quarter revenue of $725.4 million was up sharply from $479.5 million in the prior-year quarter. The company attributed continuedDemandto health plan customers that renewed their agreements and in many cases expanded the work they do with Evolent, a pattern that adds to the company's …

• Operating cash outflow was A$15.2m and investing outflow was A$22.5m, mainly from theAcquisitionof contextflow and anInvestmentin RevealDx.

Epsilon shares traded at A$0.020, down 13.04%. Its 30 October 2026 quarterly report showed receipts of A$3.9 million for the September quarter, up 34% year on year, with year-to-dateRevenueof A$11.5 million.